Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2
81Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800mammary gland integrity traitRS:0000032ACI/SegHsdfemale259 days to 143 days22CMO:0000948percentage of study population developing mammary tumors during a period of time94%MMO:0000158manual palpation method0crystalline implant17 beta-estradiol (27.5 mg) (between 193 and 199 days)6576417 beta-estradiol (27.5 mg) (between 193 and 199 days)
81Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800mammary gland integrity traitRS:0000155BN/SsNHsdfemale259 days13CMO:0000948percentage of study population developing mammary tumors during a period of time0%MMO:0000158manual palpation method0crystalline implant17 beta-estradiol (27.5 mg) (between 196 and 199 days)6576517 beta-estradiol (27.5 mg) (between 196 and 199 days)
86Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45mammary gland integrity traitRS:0000809SS-Chr 9BN/Mcwifemale162 days to 152 days40CMO:0000948percentage of study population developing mammary tumors during a period of time93%MMO:0000158manual palpation method0200 mg DMBA in 10 ml seame oilDMBA oral gavage105days7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114957,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
86Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45mammary gland integrity traitRS:0000806SS-Chr 6BN/Mcwifemale162 days to 152 days20CMO:0000948percentage of study population developing mammary tumors during a period of time20%MMO:0000158manual palpation method0200 mg DMBA in 10 ml seame oilDMBA oral gavage105days7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)114947,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
86Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45mammary gland integrity traitRS:0000805SS-Chr 5BN/Mcwifemale162 days to 152 days13CMO:0000948percentage of study population developing mammary tumors during a period of time54%MMO:0000158manual palpation method0200 mg DMBA in 10 ml seame oilDMBA oral gavage105days7,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)114937,12-dimethyltetraphene (DMBA) (65 g/kg) (for 105 days)
76Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601mammary gland integrity traitRS:0000032ACI/SegHsdfemale203 days to 201 days11CMO:0000948percentage of study population developing mammary tumors during a period of time0%MMO:0000158manual palpation methodmammary gland0bilateral ovariectomy then 17 beta-estradiol (27.5 mg) (for 140 days)11379bilateral ovariectomy17 beta-estradiol (27.5 mg) (for 140 days)
76Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601mammary gland integrity traitRS:0000032ACI/SegHsdfemale518 days to 201 days3CMO:0000948percentage of study population developing mammary tumors during a period of time0%MMO:0000158manual palpation methodmammary gland0control condition11378control condition
76Shull JD, et al., Carcinogenesis. 1997 Aug;18(8):1595-601mammary gland integrity traitRS:0000032ACI/SegHsdfemale260 days to 160 days21CMO:0000948percentage of study population developing mammary tumors during a period of time100%MMO:0000158manual palpation methodmammary gland017 beta-estradiol (27.5 mg) (for 197 days)6554917 beta-estradiol (27.5 mg) (for 197 days)
86Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45mammary gland integrity traitRS:0000803SS-Chr 3BN/Mcwifemale162 days to 152 days14CMO:0000948percentage of study population developing mammary tumors during a period of time29%MMO:0000158manual palpation method0200 mg DMBA in 10 ml seame oilDMBA oral gavage105days7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)655667,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)
144Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30mammary gland integrity traitRS:0000186COP/OlaHsdfemale330 days to 212 days7CMO:0000948percentage of study population developing mammary tumors during a period of timemean43.8%MMO:0000158manual palpation method017 beta-estradiol (27.5 mg) (between 212 and 330 days)6611317 beta-estradiol (27.5 mg) (between 212 and 330 days)
144Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30mammary gland integrity traitRS:0000032ACI/SegHsdfemale264 days to 206 days31CMO:0000948percentage of study population developing mammary tumors during a period of timemean100%MMO:0000158manual palpation method017 beta-estradiol (27.5 mg) (between 147 and 195 days)6611217 beta-estradiol (27.5 mg) (between 147 and 195 days)